Lesions of the entopeduncular nucleus in rats prevent apomorphine-induced deficient sensorimotor gating

Behavioural Brain Research

Volumn 220, Issue 2, 2011, Pages 281-287

  Lütjens, Götz ^a   Krauss, Joachim K ^a   Schwabe, Kerstin ^a  

^a HANNOVER MEDICAL SCHOOL   (Germany)

Author keywords

Basal ganglia; Globus pallidus internus; Locomotor activity; Neuropsychiatric disorder; Prepulse inhibition; Startle

Indexed keywords

APOMORPHINE; IBOTENIC ACID;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; AUDITORY MEMORY; COGNITION; CONTROLLED STUDY; ENTOPEDUNCULAR NUCLEUS; EXCITOTOXICITY; GLOBUS PALLIDUS; HYPERACTIVITY; LEARNING; LOCOMOTION; MALE; MOTIVATION; MOTOR PERFORMANCE; NEUROMODULATION; NONHUMAN; PREPULSE INHIBITION; PRIORITY JOURNAL; RAT; SENSORY GATING; STARTLE REFLEX;

ACOUSTIC STIMULATION; ANALYSIS OF VARIANCE; ANIMALS; APOMORPHINE; CONDITIONING, OPERANT; DISEASE MODELS, ANIMAL; DISEASE PROGRESSION; DOPAMINE AGONISTS; ENTOPEDUNCULAR NUCLEUS; GAIT DISORDERS, NEUROLOGIC; INHIBITION (PSYCHOLOGY); MALE; MAZE LEARNING; MOTOR ACTIVITY; RATS; RATS, SPRAGUE-DAWLEY; ROTAROD PERFORMANCE TEST; STARTLE REACTION;

EID: 79953286585     PISSN: 01664328     EISSN: 18727549     Source Type: Journal    
DOI: 10.1016/j.bbr.2011.02.006     Document Type: Article

References (57)

1. Graybiel A.M. Building action repertoires: memory and learning functions of the basal ganglia. Curr Opin Neurobiol 1995, 5:733-741.
2. Tisch S., Silberstein P., Limousin-Dowsey P., Jahanshahi M. The basal ganglia: anatomy, physiology, and pharmacology. Psychiatr Clin North Am 2004, 27:757-799.
3. Braff D.L., Geyer M.A. Sensorimotor gating and schizophrenia. Human and animal model studies. Arch Gen Psychiatry 1990, 47:181-188.
4. Swerdlow N.R., Geyer M.A. Using an animal model of deficient sensorimotor gating to study the pathophysiology and new treatments of schizophrenia. Schizophr Bull 1998, 24:285-301.
5. Koch M., Fendt M. Startle response modulation as a behavioral tool in neuropharmacology. Curr Neuropharmacol 2003, 1:175-185.
6. Swerdlow N.R., Geyer M.A., Braff D.L. Neural circuit regulation of prepulse inhibition of startle in the rat: current knowledge and future challenges. Psychopharmacology (Berl) 2001, 156:194-215.
7. Swerdlow N.R., Bakshi V., Geyer M.A. Seroquel restores sensorimotor gating in phencyclidine-treated rats. J Pharmacol Exp Ther 1996, 279:1290-1299.
8. Fendt M., Li L., Yeomans J.S. Brain stem circuits mediating prepulse inhibition of the startle reflex. Psychopharmacology (Berl) 2001, 156:216-224.
9. Kodsi M.H., Swerdlow N.R. Prepulse inhibition in the rat is regulated by ventral and caudodorsal striato-pallidal circuitry. Behav Neurosci 1995, 109:912-928.
10. Pothuizen H.H., Jongen-Relo A.L., Feldon J. The effects of temporary inactivation of the core and the shell subregions of the nucleus accumbens on prepulse inhibition of the acoustic startle reflex and activity in rats. Neuropsychopharmacology 2005, 30:683-696.
11. Koch M., Fendt M., Kretschmer B.D. Role of the substantia nigra pars reticulata in sensorimotor gating, measured by prepulse inhibition of startle in rats. Behav Brain Res 2000, 117:153-162.
12. Kretschmer B.D., Koch M. The ventral pallidum mediates disruption of prepulse inhibition of the acoustic startle response induced by dopamine agonists, but not by NMDA antagonists. Brain Res 1998, 798:204-210.
13. Bevan M.D., Clarke N.P., Bolam J.P. Synaptic integration of functionally diverse pallidal information in the entopeduncular nucleus and subthalamic nucleus in the rat. J Neurosci 1997, 17:308-324.
14. Bolam J.P., Smith Y. The striatum and the globus pallidus send convergent synaptic inputs onto single cells in the entopeduncular nucleus of the rat: a double anterograde labelling study combined with postembedding immunocytochemistry for GABA. J Comp Neurol 1992, 321:456-476.
15. Smith Y., Bevan M.D., Shink E., Bolam J.P. Microcircuitry of the direct and indirect pathways of the basal ganglia. Neuroscience 1998, 86:353-387.
16. Delong M.R., Wichmann T. Circuits and circuit disorders of the basal ganglia. Arch Neurol 2007, 64:20-24.
17. Diederich K., Koch M. Role of the pedunculopontine tegmental nucleus in sensorimotor gating and reward-related behavior in rats. Psychopharmacology (Berl) 2005, 179:402-408.
18. Schwabe K., Polikashvili N., Krauss J.K. Deficient sensorimotor gating induced by selective breeding in rats is improved by entopeduncular nucleus lesions. Neurobiol Dis 2009, 34:352-356.
19. Hadamitzky M., Harich S., Koch M., Schwabe K. Deficient prepulse inhibition induced by selective breeding of rats can be restored by the dopamine D2 antagonist haloperidol. Behav Brain Res 2007, 177:364-367.
20. Mogenson G.J., Nielsen M. A study of the contribution of hippocampal-accumbens-subpallidal projections to locomotor activity. Behav Neural Biol 1984, 42:38-51.
21. Wichmann T., Delong M.R. Functional and pathophysiological models of the basal ganglia. Curr Opin Neurobiol 1996, 6:751-758.
22. Paxinos W., Watson C. The rat brain in stereotaxic coordinates 1998, Academic Press, San Diego.
23. Galvan A., Wichmann T. GABAergic circuits in the basal ganglia and movement disorders. Prog Brain Res 2007, 160:287-312.
24. Naito A., Kita H. The cortico-nigral projection in the rat: an anterograde tracing study with biotinylated dextran amine. Brain Res 1994, 637:317-322.
25. Swerdlow N.R., Braff D.L., Geyer M.A., Koob G.F. Central dopamine hyperactivity in rats mimics abnormal acoustic startle response in schizophrenics. Biol Psychiatry 1986, 21:23-33.
26. Yee B.K., Feldon J. Distinct forms of prepulse inhibition disruption distinguishable by the associated changes in prepulse-elicited reaction. Behav Brain Res 2008, 204:387-395.
27. Frey S., Morris R., Petrides M. A neuroanatomical method to asses the integrity of fibers of passage following ibotenate-induced damage to the central nervous system. Neurosci Res 1997, 28:285-288.
28. Coffey P.J., Perry V.H., Rawlins J.N.P. An investigation into the early stages of the inflammatory response following ibotenic acid-induced neuronal degeneration. Neuroscience 1990, 35:121-132.
29. Frost S.B., Barbay S., Mumert M.L., Stowe A.M., Nudo R.J. An animal model of capsular infarct: endothelin-1 injections in the rat. Behav Brain Res 2006, 169:206-211.
30. Lecrux C., McCabe C., Weir C.J., Gallagher L., Mullin J., Touzani O., et al. Effects of magnesium treatment in a model of internal capsule lesion in spontaneously hypertensive rats. Stroke 2008, 39:448-454.
31. Braff D.L., Geyer M.A., Swerdlow N.R. Human studies of prepulse inhibition of startle: normal subjects, patient groups, and pharmacological studies. Psychopharmacology (Berl) 2001, 156:234-258.
32. Swerdlow N.R., Sutherland A.N. Using animal models to develop therapeutics for Tourette syndrome. Pharmacol Ther 2005, 108:281-293.
33. Swerdlow N.R., Sutherland A.N. Preclinical models relevant to Tourette syndrome. Adv Neurol 2006, 99:69-88.
34. Albin R.L., Mink J.W. Recent advances in Tourette syndrome research. Trends Neurosci 2006, 29:175-182.
35. Muller N. Tourette's syndrome: clinical features, pathophysiology, and therapeutic approaches. Dialogues Clin Neurosci 2007, 9:161-171.
36. Silay Y.S., Jankovic J. Emerging drugs in Tourette syndrome. Expert Opin Emerg Drugs 2005, 10:365-380.
37. Kalanithi P.S., Zheng W., Kataoka Y., DiFiglia M., Grantz H., Saper C.B., et al. Altered parvalbumin-positive neuron distribution in basal ganglia of individuals with Tourette syndrome. Proc Natl Acad Sci 2005, 102:13307-13312.
38. Kataoka Y., Kalanithi P.S., Grantz H., Schwartz M.L., Saper C., Leckman J.F., et al. Decreased number of parvalbumin and cholinergic interneurons in the striatum of individuals with Tourette syndrome. J Comp Neurol 2010, 518:277-291.
39. Houeto J.L., Karachi C., Mallet L., Pillon B., Yelnik J., Mesnage V., et al. Tourette's syndrome and deep brain stimulation. J Neurol Neurosurg Psychiatry 2005, 76:992-995.
40. Shahed J., Poysky J., Kenney C., Simpson R., Jankovic J. GPi deep brain stimulation for Tourette syndrome improves tics and psychiatric comorbidities. Neurology 2007, 68:159-160.
41. Blahak C., Wohrle J.C., Capelle H.H., Bazner H., Grips E., Weigel R., et al. Health-related quality of life in segmental dystonia is improved by bilateral pallidal stimulation. J Neurol 2008, 255:178-182.
42. Krauss J.K., Pohle T., Weber S., Ozdoba C., Burgunder J.M. Bilateral stimulation of globus pallidus internus for treatment of cervical dystonia. Lancet 1999, 354:837-838.
43. Larson P.S. Deep brain stimulation for psychiatric disorders. Neurotherapeutics 2008, 5:50-58.
44. Loher T.J., Burgunder J.M., Pohle T., Weber S., Sommerhalder R., Krauss J.K. Long-term pallidal deep brain stimulation in patients with advanced Parkinson disease: 1-year follow-up study. J Neurosurg 2002, 96:844-853.
45. Wichmann T., Delong M.R. Deep brain stimulation for neurologic and neuropsychiatric disorders. Neuron 2006, 52:197-204.
46. Albin R.L., Koeppe A., Wernette K., Zhuang W., Nichols T., Kilbourn M.R., et al. Striatal [11C]dihydrotetrabenacine and [11C]methylphenidate binding in Tourette syndrome. Neurology 2009, 72:1390-1396.
47. Singer H.S., Scymanski S., Giuliano J., Dogan A.S., Brasic J.R., Zhou Y., et al. Elevated intrasynaptic dopamine release in Tourette's syndrome measured by PET. Am J Psychiatry 2002, 159:1329-1336.
48. Wong D.F., Brasić J.R., Singer H.S., Schretlen D.J., Kuwabara H., Zhou Y., et al. Mechanisms of dopaminergic and serotonergic neurotransmission in Tourette syndrome: clues from an in vivo neurochemistry study with PET. Neuropsychopharmacology 2008, 33:1239-1251.
49. Dewar D., Jenner P., Marsden C.D. Lesions of the globus pallidus, entopeduncular nucleus and substantia nigra alter dopamine mediated circling behaviour. Exp Brain Res 1983, 52:281-292.
50. Marshall J.F., Ungerstedt U. Striatal efferent fibers play a role in maintaining rotational behavior in the rat. Science 1977, 198:62-64.
51. Olds M.E., Jacques D.B., Kopyov O. Entopeduncular lesions facilitate and thalamic lesions depress spontaneous and drug-evoked motor behavior in the hemiparkinsonian rat. Synapse 2001, 40:215-224.
52. Olds M.E., Jacques D.B., Kopyov O. Behavioral and subthalamic effects of combining a fetal ventral mesencephalic transplant in striatum with an electrolytic lesion of the entopeduncular nucleus in the rat with a unilateral 6-OHDA lesion of substantia nigra. Synapse 2003, 48:90-99.
53. Olds M.E., Jacques D.B., Kopyov O. Behavioral/neurophysiological investigation of effects of combining a quinolinic acid entopeduncular lesion with a fetal mesencephalic tissue transplant in striatum of the 6-OHDA hemilesioned rat. Synapse 2003, 49:1-11.
54. Zadow B., Schmidt W.J. Lesions of the entopeduncular nucleus and the subthalamic nucleus reduce dopamine receptor antagonist-induced catalepsy in the rat. Behav Brain Res 1994, 62:71-79.
55. Hosford D.A., McNamara J.O. Microinjection of muscimol into entopeduncular nucleus suppresses pilocarpine but not maximal electroshock seizures in rats. Brain Res 1988, 462:205-210.
56. Patel S., De Sarro G.B., Meldrum B.S. Regulation of seizure threshold by excitatory amino acids in the striatum and entopeduncular nucleus of rats. Neuroscience 1988, 27:837-850.
57. Williams S.F., Herberg L.J. Motivational vs. motor effects of striatal and pallidal gabergic projections to subthalamic and entopeduncular nuclei, ventromedial thalamus, and ventral globus pallidus. Pharmacol Biochem Behav 1987, 26:49-55.